慢性假体周围关节感染行单期翻修关节置换术的适应证:一项系统综述
该系统综述检索OVID-MEDLINE、EMBASE和Cochrane Library数据库,最终纳入22项研究、962例接受单期翻修关节置换术的感染髋或膝关节患者。复发感染率在至少两年随访时为0%至18%,在根据患者及局部软组织与骨条件筛选的患者中更低。作者结论认为单期翻修是特定患者可接受的手术治疗方式,适应证包括无严重免疫抑制、无显著软组织或骨缺损及无并发急性脓毒症,并建议对多重耐药或不典型微生物(如真菌)感染者采用两期方案。
要点
- 复发感染率在至少两年随访时为0%至18%。
- 根据患者及局部软组织与骨条件筛选的患者复发感染率更低。
- 作者建议对多重耐药或不典型微生物(如真菌)感染者采用两期方案。
核心结论
- 作者结论认为单期翻修是特定假体周围关节感染患者可接受的手术治疗方式。
- 适应证包括无严重免疫抑制、无显著软组织或骨缺损及无并发急性脓毒症。
- 作者建议对多重耐药或不典型微生物(如真菌)感染者采用两期方案。
研究设计与样本
- 系统综述,检索OVID-MEDLINE、EMBASE和Cochrane Library数据库。
- 排除患者少于10例、研究组随访不足2年的研究,以及系统综述、手术技术和专家意见。
- 初始检索875篇潜在文献,最终22篇符合纳入与排除标准。
- 纳入16项病例系列和6项比较研究;5项为前瞻性,14项为回顾性。
- 纳入962例接受感染髋或膝关节单期翻修关节置换术的患者。
主要发现
- 复发感染率在至少两年随访时为0%至18%。
- 在根据患者及局部软组织与骨条件相关因素筛选的患者中,复发感染率更低。
关键数值与推荐
- 作者提出的单期翻修适应证包括无严重免疫抑制、无显著软组织或骨缺损及无并发急性脓毒症。
- 作者建议对多重耐药或不典型微生物(如真菌)感染者采用两期方案。
临床怎么用
- 作者认为单期翻修是特定假体周围关节感染患者可接受的手术治疗方式。
- 作者建议对多重耐药或不典型微生物(如真菌)感染者采用两期方案。
局限性
- 14项研究为回顾性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Prosthetic joint infections (PJIs) of the hip and knee are associated with significant morbidity and socioeconomic burden. We undertook a systematic review of the current literature with the aim of proposing criteria for the selection of patients for a single-stage exchange arthroplasty in the management of a PJI. MATERIAL AND METHODS: A comprehensive review of the current literature was performed using the OVID-MEDLINE, EMBASE, and Cochrane Library databases and the search terms: infection and knee arthroplasty OR knee revision OR hip arthroplasty OR hip revision, and one stage OR single stage OR direct exchange. All studies involving fewer than ten patients and follow-up of less than two years in the study group were excluded as also were systematic reviews, surgical techniques, and expert opinions. RESULTS: The initial search revealed 875 potential articles of which 22 fulfilled the inclusion and exclusion criteria. There were 16 case series and six comparative studies; five were prospective and 14 were retrospective. The studies included 962 patients who underwent single stage revision arthroplasty of an infected hip or knee joint. The rate of recurrent infection ranged from 0% to 18%, at a minimum of two years' follow-up. The rate was lower in patients who were selected on the basis of factors relating to the patient and the local soft-tissue and bony conditions. CONCLUSION: We conclude that single-stage revision is an acceptable form of surgical treatment for the management of a PJI in selected patients. The indications for this approach include the absence of severe immunocompromise and significant soft-tissue or bony compromise and concurrent acute sepsis. We suggest that a two-stage approach should be used in patients with multidrug resistant or atypical organisms such as fungus.
引用
- Thakrar RR, Horriat S, Kayani B, et al. Indications for a single-stage exchange arthroplasty for chronic prosthetic joint infection: a systematic review. Bone Joint J. 2019. PMID: 30648487. doi:10.1302/0301-620X.101B1.BJJ-2018-0374.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。